BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 34433456)

  • 21. Competitive Risk Analysis of Prognosis in Older Adults with Sigmoid Colon Adenocarcinoma: A Population-Based Study.
    Du R; Guo J; Li J; Lyu J; Lyu L
    Cancer Control; 2024; 31():10732748241262184. PubMed ID: 38868954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short-term mortality risks among patients with non-metastatic bladder cancer.
    Zhai M; Tang C; Li M; Chen X; Jin Y; Ying X; Tang Z; Wang X; Wu Y; Sun C; Chen K; Guo X
    BMC Cancer; 2020 Nov; 20(1):1148. PubMed ID: 33238972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comprehensive prognostic analysis of cause-specific mortality in patients with ovarian serous cystadenocarcinoma using a competing-risks model: a case study of the SEER database.
    Chong SM; Li YJ; He Y; Chokkakula S; Ming WK; Leong NC; Zhao QQ; Chen WH; Huang CD; Deng LH; Lyu J
    Eur Rev Med Pharmacol Sci; 2023 Nov; 27(22):11143-11155. PubMed ID: 38039046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Competing risk analysis of cardiovascular/cerebrovascular death in T1/2 kidney cancer: a SEER database analysis.
    Mo X; Zhou M; Yan H; Chen X; Wang Y
    BMC Cancer; 2021 Jan; 21(1):13. PubMed ID: 33402111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developing and validating a novel nomogram used a competing-risks model for predicting the prognosis of primary fallopian tube carcinoma: a retrospective study based on the SEER database.
    Li C; Li J; Huang Q; Feng X; Zhao F; Xu F; Han D; Lyu J
    Ann Transl Med; 2021 Mar; 9(5):378. PubMed ID: 33842599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nodular lymphocyte predominant Hodgkin lymphoma: a Lymphoma Study Association retrospective study.
    Lazarovici J; Dartigues P; Brice P; Obéric L; Gaillard I; Hunault-Berger M; Broussais-Guillaumot F; Gyan E; Bologna S; Nicolas-Virelizier E; Touati M; Casasnovas O; Delarue R; Orsini-Piocelle F; Stamatoullas A; Gabarre J; Fornecker LM; Gastinne T; Peyrade F; Roland V; Bachy E; André M; Mounier N; Fermé C
    Haematologica; 2015 Dec; 100(12):1579-86. PubMed ID: 26430172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival among patients with composite and sequential lymphoma between primary mediastinal lymphoma/diffuse large B-cell lymphoma and classical Hodgkin lymphoma: A population-based study.
    Tao Y; Chen H; Liu D; Dai X
    Leuk Res; 2021 Dec; 111():106669. PubMed ID: 34333276
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Competing-Risk Nomograms for Predicting the Prognosis of Patients With Infiltrating Lobular Carcinoma of the Breast.
    Xu F; Li C; Li X; Huang Q; Han D; Wang H; Zheng S; Lyu J
    Clin Breast Cancer; 2021 Dec; 21(6):e704-e714. PubMed ID: 33846097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Model to predict cause-specific mortality in patients with olfactory neuroblastoma: a competing risk analysis.
    Liu L; Zhong Q; Zhao T; Chen D; Xu Y; Li G
    Radiat Oncol; 2021 Jun; 16(1):103. PubMed ID: 34112184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors in patients with gastric adenocarcinoma using competing-risk analysis: a study of cases in the SEER database.
    Zhang X; Yang J; Huang Q; Lyu J
    Scand J Gastroenterol; 2019 Aug; 54(8):1015-1021. PubMed ID: 31382800
    [No Abstract]   [Full Text] [Related]  

  • 31. Time Trends in Rates of Hodgkin Lymphoma Histologic Subtypes: True Incidence Changes or Evolving Diagnostic Practice?
    Glaser SL; Clarke CA; Keegan TH; Chang ET; Weisenburger DD
    Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1474-88. PubMed ID: 26215294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Competing Risk of Death in Elderly Patients with Newly Diagnosed Stage I Breast Cancer.
    Wasif N; Neville M; Gray R; Cronin P; Pockaj BA
    J Am Coll Surg; 2019 Jul; 229(1):30-36.e1. PubMed ID: 30930100
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
    Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
    Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Causes of mortality in cases with extra nodal natural killer/T-cell lymphoma, nasal type: A cohort study.
    Mei M; Wang Y; Zhang M
    PLoS One; 2019; 14(4):e0214860. PubMed ID: 30995261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of nonappendiceal cancer-specific death on overall survival: a competing risk analysis.
    Wu J; Man D; Wang K; Li L
    Future Oncol; 2019 Dec; 15(35):4083-4093. PubMed ID: 31749380
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical characteristics and prognostic factors of primary extranodal classical Hodgkin lymphoma: a retrospective study.
    Yang M; Ping L; Liu W; Xie Y; Aliya ; Liu Y; Nuersulitan R; Zhu J; Wu M; Song Y
    Hematology; 2019 Dec; 24(1):413-419. PubMed ID: 30922173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluating overall survival and competing risks of survival in patients with early-stage breast cancer using a comprehensive nomogram.
    Xu YB; Liu H; Cao QH; Ji JL; Dong RR; Xu D
    Cancer Med; 2020 Jun; 9(12):4095-4106. PubMed ID: 32314546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Different treatment regimens for primary central nervous system lymphoma:based on SEER database].
    Yang CW; Ren XH; Jiang HH; Li MX; Zhao XZ; Zhu QH; Cui Y; Lin S
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):52-58. PubMed ID: 33412634
    [No Abstract]   [Full Text] [Related]  

  • 40. Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis.
    Shen W; Sakamoto N; Yang L
    Ann Surg Oncol; 2015 Jan; 22(1):264-71. PubMed ID: 25074664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.